Successful disruption of cancer gene | Dana-Farber Cancer Institute

Posted: September 21, 2011 at 7:36 am



James Bradner, MD, and Constantine Mitsiades, MD, explain their recent study to inhibit the improper activation of the regulatory protein MYC using the molecule JQ1 and what the findings could mean for patients with multiple myeloma. Read more: http://www.dana-farber.org

View original post here:
Successful disruption of cancer gene | Dana-Farber Cancer Institute

Related Post

Comments are closed.

Archives